ClinicalTrials.Veeva

Menu
T

Tristar Clinical Investigations | Philadelphia, PA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

LY3502970
RO7795081
Orforglipron
LY3556050
Metformin
Tirzepatide
LY3298176
Retatrutide
Baloxavir Marboxil

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 8 total trials

A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

This multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-range-finding, Phase II study aims to evaluate the efficacy, tol...

Active, not recruiting
Obesity or Overweight
Drug: RO7795081
Drug: Placebo

This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additiona...

Active, not recruiting
Overweight
Obesity
Drug: Placebo
Drug: Tirzepatide

This multicenter, randomized, double-blind, placebo- and open-label active comparator-controlled, parallel-group, dose-range-finding, Phase II study...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Semaglutide
Drug: Placebo

The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent...

Active, not recruiting
Atherosclerotic Cardiovascular Disease (ASCVD)
Chronic Kidney Disease (CKD)
Drug: Retatrutide
Drug: Placebo

Trial sponsors

Lilly logo
Roche logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems